Published in Obesity and Diabetes Week, August 9th, 2010
"Male type 2 diabetic patients from Bangladesh, Pakistan and India, under glycaemic control with gliclazide...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.